Bone Marrow Stem Cell Derived Paracrine Factors for Regenerative Medicine: Current Perspectives and Therapeutic Potential

被引:110
作者
Burdon, Tom J. [1 ]
Paul, Arghya [1 ]
Noiseux, Nicolas [2 ]
Prakash, Satya [1 ]
Shum-Tim, Dominique [3 ,4 ,5 ]
机构
[1] McGill Univ, Fac Med, Dept Biomed Engn, Biomed Technol & Cell Therapy Res Lab, Montreal, PQ H3A 2B4, Canada
[2] Ctr Hosp Univ Montreal, Dept Chirurg Cardiaque, Montreal, PQ H3C 3J7, Canada
[3] McGill Univ, Montreal Gen Hosp, Div Cardiac Surg, Hlth Ctr, Montreal, PQ H3G 1A4, Canada
[4] McGill Univ, Montreal Gen Hosp, Div Surg Res, Hlth Ctr, Montreal, PQ H3G 1A4, Canada
[5] Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
D O I
10.1155/2011/207326
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
During the past several years, there has been intense research in the field of bone marrow-derived stem cell (BMSC) therapy to facilitate its translation into clinical setting. Although a lot has been accomplished, plenty of challenges lie ahead. Furthermore, there is a growing body of evidence showing that administration of BMSC-derived conditioned media (BMSC-CM) can recapitulate the beneficial effects observed after stem cell therapy. BMSCs produce a wide range of cytokines and chemokines that have, until now, shown extensive therapeutic potential. These paracrine mechanisms could be as diverse as stimulating receptor-mediated survival pathways, inducing stem cell homing and differentiation or regulating the anti-inflammatory effects in wounded areas. The current review reflects the rapid shift of interest from BMSC to BMSC-CM to alleviate many logistical and technical issues regarding cell therapy and evaluates its future potential as an effective regenerative therapy.
引用
收藏
页数:14
相关论文
共 135 条
[1]  
Al Kindi AH, 2007, CAN J CARDIOL, V23, p77C
[2]   Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes [J].
Alvarez-Dolado, M ;
Pardal, R ;
Garcia-Vardugo, JM ;
Fike, JR ;
Lee, HO ;
Pfeffer, K ;
Lois, C ;
Morrison, SJ ;
Alvarez-Buylla, A .
NATURE, 2003, 425 (6961) :968-973
[3]   Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation [J].
Annabi, B ;
Lee, YT ;
Turcotte, S ;
Naud, E ;
Desrosiers, RR ;
Champagne, M ;
Eliopoulos, N ;
Galipeau, J ;
Béliveau, R .
STEM CELLS, 2003, 21 (03) :337-347
[4]   SYNERGISTIC EFFECT OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR ON ANGIOGENESIS IN-VIVO [J].
ASAHARA, T ;
BAUTERS, C ;
ZHENG, LP ;
TAKESHITA, S ;
BUNTING, S ;
FERRARA, N ;
SYMES, JF ;
ISNER, JM .
CIRCULATION, 1995, 92 (09) :365-371
[5]   Therapeutic Applications of Mesenchymal Stem Cells to Repair Kidney Injury [J].
Asanuma, Hiroshi ;
Meldrum, Daniel R. ;
Meldrum, Kirstan K. .
JOURNAL OF UROLOGY, 2010, 184 (01) :26-33
[6]   Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes [J].
Badorff, C ;
Brandes, RP ;
Popp, R ;
Rupp, S ;
Urbich, C ;
Aicher, A ;
Fleming, I ;
Busse, R ;
Zeiher, A ;
Dimmeler, S .
CIRCULATION, 2003, 107 (07) :1024-1032
[7]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[8]   Stromal cells protect against acute tubular injury via an endocrine effect [J].
Bi, Baoyuan ;
Schmitt, Roland ;
Israilova, Malika ;
Nishio, Hitoshi ;
Cantley, Lloyd G. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (09) :2486-2496
[9]  
Bokeria L. A., 2009, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P46
[10]  
Bollini S., J MOL CELLU IN PRESS